RHHBF - Sarepta cut to Neutral at Citi on risks to valuation
2024-06-26 09:10:26 ET
More on Sarepta Therapeutics
- Sarepta Therapeutics: Pushing The Edge And Creating The Horizon
- Sarepta Therapeutics: Why Today's Rally On DMD Drug Label Expansion Won't Last
- Sarepta Therapeutics: Navigating Elevidys Upside Potential
- Trending stocks of the week: NVDA, ADSK, RKLB and more
- Biggest stock movers: PLTR, ASAN, SWBI, and more